Transparency and Disclosure Agreement – Althea
ONC Health IT Costs and Limitation Disclosure:
Complete Ambulatory EHR
This Complete Ambulatory EHR is 2015 Edition compliant and has been certified by an ONC-ACB in accordance with the applicable certification criteria adopted by the Secretary of Health and Human Services. This certification does not represent an endorsement by the U.S. Department of Health and Human Services.
Healthcare Program Transparency Disclosure:
In Support of enhanced marketplace transparency and visibility into the costs and performance of certified health IT products and services, and the business practices of the health IT developers, MD Synergy Solutions, LLC hereby attests that it will provide in a timely manner, in plain writing, and in a manner calculated to inform, any part (including all) of the information required to be disclosed under 45 CFR – 170.523(k)(1) under the following circumstances:
-To all persons who request such information.
-To all persons who request or receive a quotation, estimate, description of services, other assertion or information from MD Synergy Solutions, LLC in connection with any certified health IT or any capabilities thereof.
-To all customers prior to providing or entering into any agreement to provide any certified health IT or related product or service (including subsequent updates, add-ons, or additional products or services during the course of an on-going agreement).
-There are no additional costs or limitations that a user may encounter in the course of implementing and using the Certified Health IT’s capabilities, whether to meet meaningful use objectives and measures or to achieve any other use within the scope of the health IT’s certification.
CHPL Product Number: 15.04.04.1821.Alth.03.02.1.221205
Certified Criteria:
170.315 (a)(1): Computerized Provider Order Entry (CPOE) – Medications
170.315 (a)(2): CPOE – Laboratory
170.315 (a)(3): CPOE – Diagnostic Imaging
170.315 (a)(4): Drug-Drug, Drug-Allergy Interaction Checks for CPOE
170.315 (a)(5): Demographics
170.315 (a)(9): Clinical Decision Support
170.315 (a)(12): Family Health History
170.315 (a)(14): Implantable Device List
170.315 (a)(15): Social, Psychological, and Behavioral Determinants Data
170.315 (b)(1): Transitions of Care (Cures Update)
170.315 (b)(2): Clinical Information Reconciliation and Incorporation (Cures Update)
170.315 (b)(3): Electronic Prescribing (Cures Update)
170.315 (b)(10): Electronic Health Information Export
170.315 (c)(1): Clinical Quality Measures – Record and Export
170.315 (c)(2): Clinical Quality Measures – Import and Calculate
170.315 (c)(3): Clinical Quality Measures – Report
170.315 (d)(1): Authentication, Access Control, Authorization
170.315 (d)(2): Auditable Events and Tamper-Resistance (Cures Update)
170.315 (d)(3): Audit Report(s) (Cures Update)
170.315 (d)(4): Amendments
170.315 (d)(5): Automatic Access Time-out
170.315 (d)(6): Emergency Access
170.315 (d)(7): End-User Device Encryption
170.315 (d)(8): Integrity
170.315 (d)(9): Trusted Connection
170.315 (d)(12): Encrypt Authentication Credentials (Cures Update)
170.315 (d)(13): Multi-Factor Authentication (Cures Update)
170.315 (e)(1): View, Download, and Transmit to 3rd Party (Cures Update)
170.315 (e)(3): Patient Health Information Capture
170.315 (g)(2): Automated Measure Calculation
170.315 (g)(3): Safety-Enhanced Design
170.315 (g)(4): Quality Management System
170.315 (g)(5): Accessibility-Centered Design
170.315 (g)(6): Consolidated CDA Creation Performance (Cures Update)
170.315 (g)(7): Application Access – Patient Selection
170.315 (g)(9): Application Access – All Data Request (Cures Update)
170.315 (g)(10): Standardized API for Patient and Population Services (Cures Update)
170.315 (h)(1): Direct Project
Clinical Quality Measures:
CMS22v11: Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented
CMS68v12: Documentation of Current Medications in the Medical Record
CMS69v11: Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan
CMS122v11: Diabetes: Hemoglobin A1c (HbA1c) Poor Control (> 9%)
CMS125v11: Breast Cancer Screening
CMS130v11: Colorectal Cancer Screening
CMS131v11: Diabetes: Eye Exam
CMS133v11: Cataracts: 20/40 or Better Visual Acuity within 90 Days Following Cataract Surgery
CMS135v11: Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction (LVSD)
CMS138v11: Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention
CMS139v11: Falls: Screening for Future Fall Risk
CMS143v11: Primary Open-Angle Glaucoma (POAG): Optic Nerve Evaluation
CMS144v11: Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)
CMS145v11: Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF <40%)
CMS156v11: Use of High-Risk Medications in the Elderly
CMS165v11: Controlling High Blood Pressure
Additional Software Used:
MEDISPAN DRUG DATABASE
SURESCRIPTS HSP
MEDLINEPLUS